Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Details)

v3.8.0.1
SHARE BASED COMPENSATION (Details) - Restricted Stock
9 Months Ended
Sep. 30, 2017
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Non-vested, beginning balance, shares | shares 503,407
Vested, shares | shares (323,420)
Forfeited, shares | shares (2,062)
Non-vested, ending balance, shares | shares 449,973
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Non-vested, beginning balance, Weighted Average Grant Price (USD per share) | $ / shares $ 14.60
Vested, Weighted Average Grant Price (USD per shares) | $ / shares 14.40
Forfeited, Weighted Average Grant Price (USD per share) | $ / shares 13.29
Non-vested, ending balance, Weighted Average Grant Price (USD per share) | $ / shares $ 12.92
Non-employee directors  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 30,853
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 11.67
Employees  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 241,195
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 11.55